CN1762436A - Externally applied medicine of Ligularia lapathifolia - Google Patents
Externally applied medicine of Ligularia lapathifolia Download PDFInfo
- Publication number
- CN1762436A CN1762436A CN 200510116508 CN200510116508A CN1762436A CN 1762436 A CN1762436 A CN 1762436A CN 200510116508 CN200510116508 CN 200510116508 CN 200510116508 A CN200510116508 A CN 200510116508A CN 1762436 A CN1762436 A CN 1762436A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- seu folium
- radix seu
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The invention discloses an externally used medicament prepared from Ligularia lapathifolia (Franch.) H.-M., Mappianthus iodoides Hand-Mazz, Acanthopanax trifoliate (Linn.) Merr., umbrella polyporus, Yehuma, Radix Cinnamomi Camphorae, Pilea plataniflora C.H.Wright, croton and ethanol. The medicament can be used for treating traumatic injury, sprain, antirheumatic arthralgia and myalgia, sprain pain and rheumatic arthritis.
Description
Technical field:
The present invention relates to a kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use.
Background technology:
The traumatic injury disease is a kind of common disease, from ancient times to the present ill people is a lot, be subjected to ailing the torment, the various medicine for external use of Xiao Shouing are also a lot of in the market, slight illness for this quasi drugs treatment traumatic injury has played certain therapeutical effect really, but does not also have a kind of external specific drug of ideal treatment traumatic injury.
Summary of the invention:
The inventor is at above-mentioned weak point, and it is convenient to have a kind of treatment at patient's urgent needs, eutherapeutic medicine for external use; The inventor, verifies and by clinical trial repeatedly through research repeatedly, finally developed a kind of with low cost, prescription rationally, preparation is simple, very easy to use, compare with existing similar medicine for external use curative effect, better efficacy is a kind of medicine for external use of good traumatic injury.
Purpose of the present invention just provides a kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use.
Choice of drug Radix seu Folium Ligulariae Lapathifoliae of the present invention, Caulis Mappianthi Iodoidis, Radix Acanthopanacis Trifoliati, Rhizoma Anemones flaccidae, Herba laporteae bulbiferae (root), Radix Cinnamomi Camphorae, Radix Pileae Plataniflorae, Radix seu Folium Crotonis Laevigati, ethanol (concentration is 35%) are formed; Wherein select Radix seu Folium Ligulariae Lapathifoliae for use: have the dissipating blood stasis of dispeling the wind, promoting blood circulation and stopping pain; Control traumatic injury, pain caused by ecchymoma, bones and muscles pain due to rheumatism.Select Caulis Mappianthi Iodoidis for use: have expelling wind and removing dampness, pain relieving is active; Dispelling the wind and dampness pathogens arthralgia, rheumatoid arthritis.Select Radix Acanthopanacis Trifoliati for use: have expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation; Treating rheumatic arthritis, traumatic injury.Select Rhizoma Anemones flaccidae for use: have expelling wind and removing dampness, relaxing muscles and tendons to promote blood circulation; Dispelling the wind and dampness pathogens pain, traumatic injury.Select Herba laporteae bulbiferae (root) for use: have expelling wind and removing dampness, relaxing muscles and tendons and activating QI and blood in the collateral; The dispelling the wind and dampness pathogens arthralgia.Select Radix Cinnamomi Camphorae for use: have expelling wind and removing dampness, removing blood stasis and activating blood flow; The dispelling the wind and dampness pathogens arthralgia, traumatic injury, bones and muscles pain.Select Radix Pileae Plataniflorae for use: have activating collaterals to relieve pain, expelling wind and removing dampness; Control traumatic injury, rheumatic arthritis.Select Radix seu Folium Crotonis Laevigati for use: have and restore menstrual flow and invigorate blood circulation dissipating blood stasis for subsidence of swelling; Control traumatic injury.Make the effect of each medicine produce collaborative effect these drug regimens, thereby can realize effectively treating traumatic injury, pain caused by ecchymoma, rheumatism bones and muscles pain, muscles and bones sprain pain, traumatic injury sprain and contusion hinder, sprain swell and ache, the disease of soft tissue contusion, osteopatia sprain, Fengshi Guanjie pain, rheumatic arthritis pain, rheumatoid arthritis, curative effect is illustrious.
The consumption of drug component of the present invention also is to carry out a large amount of solid lines through the inventor to grope to sum up and draw, and each amounts of components is for all to have better therapeutic effect in the following weight parts scope; It is made up of the component of following parts by weight:
Radix seu Folium Ligulariae Lapathifoliae 1-10, Caulis Mappianthi Iodoidis 1-10 part, Radix Acanthopanacis Trifoliati 1-10 part, Rhizoma Anemones flaccidae 1-10 part, Herba laporteae bulbiferae (root) 1-10 part, Radix Cinnamomi Camphorae 1-10 part, Radix Pileae Plataniflorae 1-10 part, Radix seu Folium Crotonis Laevigati 1-10 part, ethanol (concentration is 35%) 32-320 part.
Optimization formula of the present invention is:
7 parts of Radix seu Folium Ligulariae Lapathifoliae, 7 parts of Caulis Mappianthi Iodoidiss, 7 parts of Radix Acanthopanacis Trifoliatis, 7 parts of Rhizoma Anemones flaccidae, 7 parts of Herba laporteae bulbiferaes (root), 7 parts of Radix Cinnamomi Camphoraes, 7 parts of Radix Pileae Platanifloraes, 7 parts of Radix seu Folium Crotonis Laevigati, 224 parts of ethanol (concentration is 35%).
A kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use of the present invention has relaxing muscles and tendons and activating QI and blood in the collateral, promoting blood circulation to remove blood stasis, an effect of the analgesia of dispeling the wind; Be a kind of with low cost, prescription rationally, preparation is simple, easy to use, compares with existing similar medicine for external use curative effect, Radix seu Folium Ligulariae Lapathifoliae medicine for external use curative effect is fine.Radix seu Folium Ligulariae Lapathifoliae medicine for external use of the present invention was once done a large amount of clinical trials in early stage, give on the patient treatment case surplus in the of tens example time, comprise be used for the treatment of traumatic injury, pain caused by ecchymoma, rheumatism bones and muscles pain, muscles and bones sprain pain, traumatic injury sprain and contusion hinder, sprain swell and ache, the disease of soft tissue contusion, osteopatia sprain, Fengshi Guanjie pain, rheumatic arthritis pain, rheumatoid arthritis, do not see untoward reaction during the treatment.Total effective rate is more than 82%, and curative effect is illustrious.
Using method:
This medicine is a medicine for external use, and oral administration is at first cleaned the affected part with hot water, will dab in the affected part with the drenched medicinal liquid of absorbent cotton, and be good with palm of the hand stranding or the heating of tip-tap affected part then, every day 3-6 time.
The specific embodiment:
Describe embodiments of the invention below in detail:
Embodiment 1:
A kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use provided by the present invention is made up of the component of following parts by weight; Radix seu Folium Ligulariae Lapathifoliae 1-10, Caulis Mappianthi Iodoidis 1-10 part, Radix Acanthopanacis Trifoliati 1-10 part, Rhizoma Anemones flaccidae 1-10 part, Herba laporteae bulbiferae (root) 1-10 part, Radix Cinnamomi Camphorae 1-10 part, Radix Pileae Plataniflorae 1-10 part, Radix seu Folium Crotonis Laevigati 1-10 part, ethanol (concentration is 35%) 32-320 part.
Embodiment 2:
Optimization formula of the present invention is:
7 parts of Radix seu Folium Ligulariae Lapathifoliae, 7 parts of Caulis Mappianthi Iodoidiss, 7 parts of Radix Acanthopanacis Trifoliatis, 7 parts of Rhizoma Anemones flaccidae, 7 parts of Herba laporteae bulbiferaes (root), 7 parts of Radix Cinnamomi Camphoraes, 7 parts of Radix Pileae Platanifloraes, 7 parts of Radix seu Folium Crotonis Laevigati, 224 parts of ethanol (concentration is 35%).
Preparation method of the present invention is: at first with above-mentioned Radix seu Folium Ligulariae Lapathifoliae, Caulis Mappianthi Iodoidis, Radix Acanthopanacis Trifoliati, Rhizoma Anemones flaccidae, Herba laporteae bulbiferae (root), Radix Cinnamomi Camphorae, Radix Pileae Plataniflorae, Radix seu Folium Crotonis Laevigati, the single short fragment that is cut into respectively, each single short fragment that is cut into is mixed in proportion together, be placed in the container then, and allocate ethanol (concentration is 35%) into, stir the back sealed container in, according to the modern Chinese medicine processing technology or after soaking 10-15 days, the mixture solution after handling packed into by the required metering of client to get product in the bottle.
Claims (3)
1, a kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use is characterized in that: Radix seu Folium Ligulariae Lapathifoliae, Caulis Mappianthi Iodoidis, Radix Acanthopanacis Trifoliati, Rhizoma Anemones flaccidae, Herba laporteae bulbiferae (root), Radix Cinnamomi Camphorae, Radix Pileae Plataniflorae, Radix seu Folium Crotonis Laevigati, ethanol (concentration is 35%).
2, a kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; Radix seu Folium Ligulariae Lapathifoliae 1-10, Caulis Mappianthi Iodoidis 1-10 part, Radix Acanthopanacis Trifoliati 1-10 part, Rhizoma Anemones flaccidae 1-10 part, Herba laporteae bulbiferae (root) 1-10 part, Radix Cinnamomi Camphorae 1-10 part, Radix Pileae Plataniflorae 1-10 part, Radix seu Folium Crotonis Laevigati 1-10 part, ethanol 32-320 part.
3, a kind of Radix seu Folium Ligulariae Lapathifoliae medicine for external use according to claim 1, it is characterized in that: the component by following parts by weight is formed; 7 parts of Radix seu Folium Ligulariae Lapathifoliae, 7 parts of Caulis Mappianthi Iodoidiss, 7 parts of Radix Acanthopanacis Trifoliatis, 7 parts of Rhizoma Anemones flaccidae, 7 parts of Herba laporteae bulbiferaes (root), 7 parts of Radix Cinnamomi Camphoraes, 7 parts of Radix Pileae Platanifloraes, 7 parts of Radix seu Folium Crotonis Laevigati, 224 parts of ethanol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510116508 CN1762436A (en) | 2005-10-07 | 2005-10-07 | Externally applied medicine of Ligularia lapathifolia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510116508 CN1762436A (en) | 2005-10-07 | 2005-10-07 | Externally applied medicine of Ligularia lapathifolia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1762436A true CN1762436A (en) | 2006-04-26 |
Family
ID=36746895
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510116508 Pending CN1762436A (en) | 2005-10-07 | 2005-10-07 | Externally applied medicine of Ligularia lapathifolia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1762436A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841228A (en) * | 2021-01-12 | 2021-05-28 | 中国农业大学 | Application of Huaxuedan in aspects of killing mites and pests, biological control medicament and preparation method thereof |
-
2005
- 2005-10-07 CN CN 200510116508 patent/CN1762436A/en active Pending
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112841228A (en) * | 2021-01-12 | 2021-05-28 | 中国农业大学 | Application of Huaxuedan in aspects of killing mites and pests, biological control medicament and preparation method thereof |
| CN112841228B (en) * | 2021-01-12 | 2022-02-08 | 中国农业大学 | Application of Huaxuedan in aspects of killing mites and pests, biological control medicament and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742895A (en) | External-use medicine of Herba sarcandrae | |
| CN1739620A (en) | Externally applied for dispelling wind and dredging meridian passage | |
| CN1742816A (en) | Wujiaofeng root external-use medicine | |
| CN1813944A (en) | External-use drug of securidaca inappendiculata hassk for traumatic injury and activating collaterals | |
| CN1814134A (en) | Collateral-flow-activating external-use medicine of Radix Seu Folium Clematidis Henryi for treating injuries by falls | |
| CN1762436A (en) | Externally applied medicine of Ligularia lapathifolia | |
| CN1762469A (en) | Externally applied medicine of madeira vine | |
| CN1742801A (en) | Qianjinba external-use medicine | |
| CN1739693A (en) | Externally applied medicine of dunn tongoloa root | |
| CN1739624A (en) | Externally applied medicine of aizoon stonecrop root | |
| CN1813898A (en) | External-use medicine of hayberry bark for traumatic injury and activating collaterals | |
| CN1762479A (en) | Externally applied medicine of stahlianthus involucratus | |
| CN1742815A (en) | External-use medicine of lysimachia root | |
| CN1742907A (en) | External-use medicine of Radix celastri orbiculati | |
| CN1814087A (en) | Wind-repellent collateral-activating pain-relieving medicine of Herba clemati dis Intricatae | |
| CN1742839A (en) | Nutritious health-care oral liquor for woman and preparing process | |
| CN1742961A (en) | External-use medicine of Rhizome cyperi | |
| CN1813963A (en) | External medicine of Herbaet Rhizoma Begoniae cavalerei for treating traumatic injuries and activating collateral flows | |
| CN1739646A (en) | Externally applied medicine of thickleaf croton root | |
| CN1742857A (en) | Berchemia sinica schneid external-use medicine | |
| CN1739636A (en) | Externally applied medicine of Chinese tinospora stem | |
| CN1813854A (en) | External-use medicine of herb of seguin cobelia for traumatic injury and activating collaterals | |
| CN1742856A (en) | Radix aconitic kusnezoffii external-use medicine | |
| CN1739649A (en) | Externally applied wound treating medicine of miquel brookweed | |
| CN1742972A (en) | External-use medicine of Herba chloranthi multistachydis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |